Features:  Facilitates research on ANY patient chart datapoint(s)
 

1. Base abstraction encompasses Federal CDC COVID data dictionary
      Demographics, COVID status, co-morbidities

2.  Expandable abstraction to include additional elements
       State CDC and healthcare facilities can abstract using Rx, prior hospitalizations, other co-morbidities
       Subsequent research can expand set of element for recursive analysis

3. Abstraction tool enables drill down to patient level data

.

 Features: Saves time of medical professional by reducing workflow interruptions
                      Empower epidimiologists to keep citizens safe and FULLY informed;

1. Automated acquisition of robust COVID19 dataset
    a. Avoid time consuming CDC forms
    b. Minimizes staff workflow interruptions
    c. Leverages  EHR functions already installed at provider's site
    d. Uses existing ACA processes

2. Full support of Federal COVID19 Data Dictionary
       A. Demographics, Co-morbidities, mortality, hospitalizations…

3. Site Extensible Data Dictionary
     Each Site can define additional datapoints (Example: Rx, prior hospitalizations)

 

Feature: Our report generator keeps your citizens informed of the latest progress using multiple formats
 

1. Selectable Epidemiology report: Incremental, Differential, Date range, Locality
2. Web interface report
     a. Enables aggregate analysis

         b. With optional  drill down to patient level datasets.
3. Google maps reports
     a. Show geographic distribution of metrics over time
4. Programmers API

Our baseline of datapoints is defined by the US CDC and is comprised of 4 parts:

• Patient demographic information,

• COVID-19 diagnosis and course of illness

• Co-morbidities

• Information about the healthcare professional.

Our system uniquely allows state CDC and healthcare professionals to include other biometric data points normally included in the electronic patient chart(*).

Top goals of the registry include:

•             Understanding the outcomes of patients with CDC listed conditions who develop COVID-19 and the influence of their comorbidities and medications on their outcomes.

•             Understanding the influence of medications, such as hydroxychloroquine, on the outcomes of patients who develop COVID-19.

•             Rapidly performing systematic reviews of the currently available literature regarding conditions and medications in patients who develop COVID-19 and updating them frequently while the pandemic is still active globally.

•             Exploring the patient experience during the COVID-19 pandemic.

Ultimately, we felt that building a worldwide registry was the best way to contribute reliable, evidence-based information and resources desperately needed in these rapidly evolving discussions."

The CUSHM Global COVID-19 Alliance is asking that clinicians use the registry to report any and all cases of COVID-19 in patients, including those with mild or no symptoms.

It is anticipated that the online case report form will take five to 10 minutes to complete and no protected health information is requested.

(*)
The dataset can include any information as designate by the HL7 International CCDA, including:

HL7 Consult Note 2. HL7 Diagnostic Imaging Report 3. HL7 Discharge Summary 4. HL7 History and Physical 5. HL7 Operative Note 6. HL7 Procedure Note 7. HL7 Unstructured Documents 8. HL7 Progress Notes 9. HL7 Continuity of Care Document 10.HITSP/C84 Consult and History & Physical Note Document 11.HITSP/C32 - Summary Documents Using HL7 CCD 12.HITSP/C48 Referral and Discharge Summary 13.HITSP/C62 Scanned document

.